Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Woburn, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Comera Life Sciences Holdings, Inc. has filed 298 SEC EDGAR filings since 03 Feb 2022

SEC filing history

Showing 1-25 of 298 matching filings.

Per page
25
Current page
1
EFFECT File 333-274253

EFFECT filing

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-269564

EFFECT filing

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267283

EFFECT filing

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264686

EFFECT filing

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-274485

S-8 POS

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-270679

S-8 POS

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-266824

S-8 POS

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-274253

POS AM

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-269564

POS AM

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-267283

POS AM

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-264686

POS AM

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 333-263377

25-NSE filing

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Feb 2024
Reporting date
29 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
02 Feb 2024
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-267283

424B3

Filing date
30 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264686

424B3

Filing date
30 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-269564

424B3

Filing date
30 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jan 2024
Reporting date
29 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
11 Jan 2024
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Jan 2024
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Jan 2024
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Jan 2024
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-501778

D filing

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .